Study how chronic marijuana affects brain inflammation in HIV
Part of Mental health clinical trials.
This study looks at whether ongoing marijuana use changes “brain inflammation” and brain cell injury in people living with HIV. It may help researchers understand potential risks or protective effects and how treatment and brain health interact.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a verified HIV diagnosis, if you’re in the HIV group
- You must match the study’s marijuana group: currently using marijuana or not currently using it
- If you have HIV, you must be actively engaged in HIV care
- If you have HIV, you must be on your first-line HIV medicines (cART) and on a stable dose for a while
- If you have HIV, your viral load must have stayed “undetectable” for more than 1 year
- You generally must not have major brain/neurologic conditions or MRI safety issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether cannabidiol (CBD) and tetrahydrocannabinol (THC) change the gut microbiome and brain-related inflammation in people with HIV. It may help researchers understand new ways to reduce inflammation, but you would need strict cannabis and CBD/THC avoidance during the study.
This study looks at brain activity to understand how depression and cannabis use may be linked in young adults living with HIV. It mainly involves questionnaires, mental health screening, and brain scans, which may help researchers better understand risk factors and brain “underpinnings.”
This study looks at how depression and its treatment may affect the brain and immune-related body systems in people with HIV. You may be eligible if you have depression and a well-controlled HIV viral load, and you can safely complete brain MRI scans.
This study looks at how alcohol use affects people with HIV who take multiple medications, including certain brain or nerve drugs. It aims to find safer ways to manage their health.
This study looks at how body inflammation and lung health relate to the movement of fungi in the body of people living with HIV. The goal is to better understand what factors may affect lung problems and fungal “translocation,” which may help future care.
This Phase 2 study looks at whether lowering inflammation can help improve depression symptoms in adults living with HIV. You may be able to join if your HIV is well controlled and you are currently experiencing major depression (or a certain type of bipolar depression).
Hear when a new Cannabis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.